Close
Nordic 9Nordic 9

Vaxinano (private company)

France vaxinano.com
See something wrong or missing? Let us know
Offices:Lille
Industry:BiotechHealth servicesManufacturingPharma
Business model:B2B

Vaxinano is a clinical-stage biotechnology startup from France, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.66M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Vaxinano

Name Criteria
Denmark Biograil
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
France Cell-Easy
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Norway Curida
63%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Denmark Octarine Bio
63%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Austria Sarcura
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
Spain ViveBiotech
63%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Italy Harg
63%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
Germany Exciva
63%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top